Selcia has opened its new state-of-the-art laboratory dedicated to the manufacture of 14C radiolabelled GMP API drug substance. The company says its radiolabelling business is growing at a fast pace and this expansion will help meet the increasing demand for 14C radiolabelled compounds. Such radiolabelled compounds are used to help understand the pharmacokinetic behavior of parent drug and human specific metabolites in first-in-man studies. “The investment in this new facility allows Selcia t...